PATENT CLAIM ANALYSIS

Application Number: 16116559
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["544", "281000"]

Abstract:
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and solid forms of the compounds of this invention. The compounds of this invention have formula I-1 or I-A: wherein the variables are as defined herein.

Claim (Index 5):
The compound of  claim 1 , wherein Y 1 , Y 3 , and Y 4  are independently deuterium or hydrogen; and Y 2 , Y 5 , Y 6 , and Y 7  are deuterium.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 96.0
- Lexical Diversity: 1.97917
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13631732', '15849241', '14561368', '14678489', '15597806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7802565082128508
- 35 USC 102 Novelty (BERT): 0.4901500892814499
- Combined Prediction Score: 0.7512458663197107
- Mean Citation Score: 219.594414
- Max Citation Score: 227.33057
- Similarity Product: 165.56444203884124

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test